 |
|||||||||
|
|||||||||
 |
Financial and Operating Results
| Consolidated Financial Data |
Others
 |
 |
 |
|
 |
 |
|
|
 |
 |
Millions of yen |
|||||
2004/3 |
2005/3 |
2006/3 |
2007/3 |
2008/3 |
|
| Capital expenditures | 1,842 |
2,839 |
3,166 |
3,869 |
1,612 |
| Depreciation and amortization | 2,513 |
2,273 |
2,314 |
2,375 |
2,784 |
| Free cash flows | 5,878 |
7,123 |
6,918 |
2,330 |
19,396 |
| R&D expenses | 3,892 |
3,986 |
4,830 |
5,385 |
6,008 |
| R&D expense ratio [%] | 3.8 |
3.6 |
3.8 |
3.8 |
3.9 |
| Number of employees [persons] | 2,306 |
2,300 |
2,320 |
2,426 |
2,506 |
| Net sales per employee | 45.03 |
48.55 |
54.92 |
59.79 |
62.79 |
|
|||
| Free cash flows = Cash flows from operating activities - Capital expenditures | |||
| R&D expense ratio = R&D expenses/Net sales × 100 [%] | |||
| Net sales per employee = Net sales/Average number of employees |
